Nightingale Health Oyj Statistics
Total Valuation
HEL:HEALTH has a market cap or net worth of EUR 138.95 million. The enterprise value is 91.31 million.
Market Cap | 138.95M |
Enterprise Value | 91.31M |
Important Dates
The last earnings date was Thursday, September 18, 2025.
Earnings Date | Sep 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
HEL:HEALTH has 60.28 million shares outstanding. The number of shares has increased by 0.97% in one year.
Current Share Class | 40.54M |
Shares Outstanding | 60.28M |
Shares Change (YoY) | +0.97% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 28.28% |
Owned by Institutions (%) | 5.84% |
Float | 35.05M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 29.61 |
PB Ratio | 2.10 |
P/TBV Ratio | 2.44 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -4.95 |
EV / Sales | 19.46 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.37 |
Financial Position
The company has a current ratio of 8.80, with a Debt / Equity ratio of 0.05.
Current Ratio | 8.80 |
Quick Ratio | 8.52 |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | -0.29 |
Interest Coverage | -15.03 |
Financial Efficiency
Return on equity (ROE) is -24.77% and return on invested capital (ROIC) is -15.60%.
Return on Equity (ROE) | -24.77% |
Return on Assets (ROA) | -14.65% |
Return on Invested Capital (ROIC) | -15.60% |
Return on Capital Employed (ROCE) | -28.37% |
Revenue Per Employee | 46,930 |
Profits Per Employee | -184,610 |
Employee Count | 100 |
Asset Turnover | 0.06 |
Inventory Turnover | 0.94 |
Taxes
In the past 12 months, HEL:HEALTH has paid 53,000 in taxes.
Income Tax | 53,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.71% in the last 52 weeks. The beta is 0.48, so HEL:HEALTH's price volatility has been lower than the market average.
Beta (5Y) | 0.48 |
52-Week Price Change | -25.71% |
50-Day Moving Average | 2.36 |
200-Day Moving Average | 2.70 |
Relative Strength Index (RSI) | 46.92 |
Average Volume (20 Days) | 51,045 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HEL:HEALTH had revenue of EUR 4.69 million and -18.46 million in losses. Loss per share was -0.30.
Revenue | 4.69M |
Gross Profit | 3.54M |
Operating Income | -19.38M |
Pretax Income | -18.41M |
Net Income | -18.46M |
EBITDA | -14.50M |
EBIT | -19.38M |
Loss Per Share | -0.30 |
Balance Sheet
The company has 51.21 million in cash and 3.57 million in debt, giving a net cash position of 47.64 million or 0.79 per share.
Cash & Cash Equivalents | 51.21M |
Total Debt | 3.57M |
Net Cash | 47.64M |
Net Cash Per Share | 0.79 |
Equity (Book Value) | 66.17M |
Book Value Per Share | 1.10 |
Working Capital | 48.41M |
Cash Flow
In the last 12 months, operating cash flow was -10.11 million and capital expenditures -2.28 million, giving a free cash flow of -12.39 million.
Operating Cash Flow | -10.11M |
Capital Expenditures | -2.28M |
Free Cash Flow | -12.39M |
FCF Per Share | -0.21 |
Margins
Gross Margin | 75.39% |
Operating Margin | -412.96% |
Pretax Margin | -392.24% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
HEL:HEALTH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.97% |
Shareholder Yield | n/a |
Earnings Yield | -13.29% |
FCF Yield | -8.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HEL:HEALTH has an Altman Z-Score of 11.05 and a Piotroski F-Score of 3.
Altman Z-Score | 11.05 |
Piotroski F-Score | 3 |